
|Articles|February 1, 2016
The Cannabis Analytical Conundrum
Author(s)SCIEX
Recently several states have legalized recreational and medical marijuana. This has created a confusing set of circumstances due to legalization at the state level, but cannabis is still an illegal schedule 1 drug at the federal level. This confusion also affects the development of analytical methods because there are no clear guidelines available to laboratories. This whitepaper will discuss the following topics: • Overview of state analytical requirements • Discussion of analytical method development for cannabinoids and related compounds of interest • Discussion of method performance
Advertisement
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
A Look at the Major Technical Themes of ASMS 2026
2
LC-MS Links Gut Metabolites to Anxiety Therapy
3
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
4
Mass Spectrometry Approaches for Investigating Alpha-Synuclein Structural Changes in Neurodegenerative Disease
5




